about
The Promise of Integrins as Effective Targets for Anticancer AgentsThe urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motilityAFAP1L1, a novel associating partner with vinculin, modulates cellular morphology and motility, and promotes the progression of colorectal cancersTargeted therapies for killing tumor cells.Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.Association between ITGA2 C807T polymorphism and gastric cancer risk.Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model.Phosphoinositides in cell architecture.Cyclin D1 governs adhesion and motility of macrophages.Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression.Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility.Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins.Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway.Integrin beta1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivoIntegrin dependence of Calu-1 cell motility on endothelial extracellular matrix proteinsContributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis.Integrins in prostate cancer progressionThe role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors.Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.Novel 3-D cell culture system for in vitro evaluation of anticancer drugs under anchorage-independent conditions.The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines.beta1 integrin is necessary for ureteric bud branching morphogenesis and maintenance of collecting duct structural integrity.Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signalingLebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells.Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate.Regulation of beta1C and beta1A integrin expression in prostate carcinoma cells.Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons.Updating the research on the chemopreventive and therapeutic role of the peptide lunasin.High-level β1-integrin expression in a subpopulation of highly tumorigenic oral cancer cells.Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
P2860
Q24801503-1E69F6BB-8F26-41F5-96CA-73864A1E33A0Q28212178-63A25EDD-6E56-4F8F-9B0C-14A36B1487FBQ28386237-5F0498F3-3C33-42FC-8713-6B448AF992CFQ33942895-0B61149C-2F50-441F-BC76-FAC986FA400AQ35042977-3BEF409A-4555-4B92-9D04-AA0D29A2A92EQ35061943-D6776FD6-15F3-4117-AD81-DC98D5495001Q35098301-6F2F2581-80D3-48A0-97DB-6C04357624F7Q35119240-3DCDCC02-7B51-4363-A893-C55B66A2A3EFQ35153599-72126B6F-20E1-4961-8B17-A1FD8179CA43Q36106835-26B4C1B4-E520-4CCC-A673-A6DCB076DFF6Q36225840-9473E4D0-0A43-460E-A729-2CF16F27E196Q36322135-30CE7E3A-2705-4F46-96B2-FFC35BFA5355Q36322254-67F03618-42F5-47EF-BB3B-B8F62C013FA0Q36503284-1512D2C9-7FAD-4484-AE56-9EDF5A153FC9Q36615726-8F7B6B04-33F0-42B7-9A77-D1D6789A3117Q36841905-F1B82A03-91FC-495D-A79B-9598BA310D22Q37118092-5AF216DA-A035-458F-A7F4-06342DED132FQ37182177-BEDC646E-2BB7-44F9-8C9A-9DCAA498E929Q37604903-E2C7DE3C-0D72-4E9A-9E9B-0926D327E0D1Q37800462-67575A51-D78B-44E5-AA3F-E68603165CE6Q38331308-1B02C588-4561-4329-9224-6304DA8EA77CQ38363956-AD8AABE0-9D4F-4063-93F9-283CFAF1E66DQ38742565-8C2584C7-87B9-47AB-80B6-D4C558A8F5D4Q39502453-41F9055C-A887-44C4-9C54-716E6C9392B6Q39807801-3E288B1A-821B-4BFA-8D5C-C81B8C5ABFF1Q40440867-CC515B2E-2264-434B-9DC6-AB6D832707B6Q40572580-CE828E7E-DAF6-417F-80EE-02295B9CDFE9Q40621321-BABC0A11-FEFD-4FC2-A5D5-4BF9796E7397Q40621534-9F26B419-9ED8-469E-86DC-3EF1233571A0Q42072153-3053643C-D603-4C92-B9DE-7F17B0431C2AQ46000042-1F057414-9C7F-4B9E-A0B9-1A9375CCA457Q46413521-822D6AA5-3563-4AA4-A8D6-E7597CCC6996Q46699463-2A798B68-16C6-4FAE-AD93-410C0DDC4473
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
New aspects of integrin signaling in cancer.
@ast
New aspects of integrin signaling in cancer.
@en
New aspects of integrin signaling in cancer.
@nl
type
label
New aspects of integrin signaling in cancer.
@ast
New aspects of integrin signaling in cancer.
@en
New aspects of integrin signaling in cancer.
@nl
prefLabel
New aspects of integrin signaling in cancer.
@ast
New aspects of integrin signaling in cancer.
@en
New aspects of integrin signaling in cancer.
@nl
P2093
P356
P1476
New aspects of integrin signaling in cancer.
@en
P2093
P304
P356
10.1006/SCBI.2000.0337
P577
2000-12-01T00:00:00Z